"Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
| Descriptor ID |
D014612
|
| MeSH Number(s) |
D20.215.894
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Vaccines".
This graph shows the total number of publications written about "Vaccines" by people in this website by year, and whether "Vaccines" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 |
| 1996 | 4 | 1 | 5 |
| 1997 | 2 | 1 | 3 |
| 1999 | 2 | 1 | 3 |
| 2000 | 2 | 0 | 2 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 1 | 3 |
| 2003 | 3 | 3 | 6 |
| 2004 | 7 | 4 | 11 |
| 2005 | 2 | 4 | 6 |
| 2006 | 6 | 2 | 8 |
| 2007 | 7 | 4 | 11 |
| 2008 | 3 | 3 | 6 |
| 2009 | 13 | 9 | 22 |
| 2010 | 7 | 7 | 14 |
| 2011 | 14 | 2 | 16 |
| 2012 | 5 | 3 | 8 |
| 2013 | 7 | 7 | 14 |
| 2014 | 21 | 4 | 25 |
| 2015 | 9 | 5 | 14 |
| 2016 | 15 | 4 | 19 |
| 2017 | 21 | 2 | 23 |
| 2018 | 10 | 4 | 14 |
| 2019 | 9 | 7 | 16 |
| 2020 | 11 | 4 | 15 |
| 2021 | 28 | 1 | 29 |
| 2022 | 66 | 6 | 72 |
| 2023 | 50 | 0 | 50 |
| 2024 | 10 | 6 | 16 |
Below are the most recent publications written about "Vaccines" by people in Profiles.
-
Advanced technologies for the development of infectious disease vaccines. Nat Rev Drug Discov. 2024 12; 23(12):914-938.
-
Characteristics of Vaccine Safety Observational Studies and Authors' Attitudes: A Systematic Review. Am J Med. 2025 Feb; 138(2):254-261.e5.
-
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019. Pediatrics. 2024 Oct 01; 154(4).
-
Structure-Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine Adjuvants. J Med Chem. 2024 Aug 22; 67(16):13703-13722.
-
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):688-704.
-
Administration sequence- and formation-dependent vaccination using acid-degradable polymeric nanoparticles with high antigen encapsulation capability. J Mater Chem B. 2024 Jul 10; 12(27):6577-6586.
-
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nat Med. 2024 Apr; 30(4):1013-1022.
-
A multi-omics systems vaccinology resource to develop and test computational models of immunity. Cell Rep Methods. 2024 Mar 25; 4(3):100731.
-
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects. Front Immunol. 2024; 15:1345499.
-
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity. 2024 03 12; 57(3):587-599.e4.